Strategic Acquisitions, Quarterly Financial Results and Updated Earnings Guidance - Research Report on CSC, Cerner, WebMD, Medidata, and MedAssets PR Newswire NEW YORK, November 7, 2013 NEW YORK, November 7, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Computer Sciences Corporation (NYSE: CSC), Cerner Corporation (NASDAQ: CERN), WebMD Health Corp. (NASDAQ: WBMD), Medidata Solutions, Inc. (NASDAQ: MDSO), and MedAssets, Inc. (NASDAQ: MDAS). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Computer Sciences Corporation Research Report On October 30, 2013, Computer Sciences Corporation (CSC) announced that it has signed a definitive agreement to acquire ServiceMesh, an enterprise cloud management company. CSC informed that the acquisition allows the Company to continue its transformation into a next-generation IT company that helps clients migrate their applications into cloud computing environments. "ServiceMesh allows us to catalogue enterprise applications and orchestrate those applications dynamically to run in different clouds based on the characteristics of the applications. From our unique position as an independent global technology company, we will integrate those workloads for our clients through our portfolio of services and technologies," said Mike Lawrie, President and CEO of CSC. "With ServiceMesh, we will empower an ecosystem of enterprise software providers by lowering the friction for companies to execute a multi-vendor hybrid cloud strategy while maintaining central governance, policy and administration," added Dan Hushon, Chief Technology Officer of CSC. The Companies expect the transaction to close in Q3 FY 2014. The Full Research Report on Computer Sciences Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/7438_CSC] Cerner Corporation Research Report On October 24, 2013, Cerner Corporation (Cerner) reported its Q3 2013 financial results. During the quarter, the Company's revenue increased 7.6% YoY to $727.8 million. Cerner said that the revenue growth was below its expectations due to reduced levels of low-margin technology resale. The Company reported Q3 2013 GAAP net earnings of $115.3, or $0.33 per diluted share, which were in line with Cerner's expectations, and higher when compared to net earnings of $98.9 million, or $0.28 per diluted share in Q3 2012. "In addition to our solid financial results, our third quarter included several very strategic client wins across the globe and major development and deployment milestones for our population health and mobility solutions," said Neal Patterson, Chairman, CEO, and Co-founder of Cerner. "Cerner has done well and we believe will continue to do well in the current electronic medical record era, but it's our investments in capabilities beyond the EMR that differentiate us from our current competitors and position us for sustained growth through the decade." The Full Research Report on Cerner Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/83ac_CERN] WebMD Health Corp. Research Report On October 29, 2013, WebMD Health Corp. (WebMD) announced that it has acquired Avado, Inc. (Avado), a developer of cloud-based patient relationship management (PRM) tools and technologies that enable better communication between consumers and health care professionals. "Our acquisition of Avado demonstrates WebMD's commitment to playing a leading role in the emerging patient relationship management space because we believe that connectivity has the potential to make the delivery of care more efficient and improve patient outcomes," said David Schlanger, CEO of WebMD. "Avado's innovative technology and tools will complement, and further accelerate WebMD's efforts to connect patients with their healthcare providers, which is an important first step toward making connected care a reality," added Bill Pence, COO and Chief Technology Officer of the Company. The Company informed that Dave Chase and Bassam Saliba, Avado's founders, will continue with Avado and will report to Pence. The Full Research Report on WebMD Health Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/c4b8_WBMD] Medidata Solutions, Inc. Research Report On October 24, 2013, Medidata Solutions, Inc. (Medidata) reported its Q3 2013 financial results. During the quarter, the Company's revenues increased 27.1% YoY to $70.9 million. During the quarter, GAAP net income came in at $5.3 million, or $0.20 per diluted share, compared with $4.1 million, or $0.16 per diluted share, in Q3 2012. "Current and new customers are increasingly choosing to work on the Medidata Clinical Cloud to drive innovation and improve productivity in their clinical development efforts," said Tarek Sherif, Chairman and CEO of Medidata. "Given our strong performance year to date, solid backlog coverage, industry leading revenue retention and a healthy pipeline of future opportunities, we are once again raising our 2013 guidance," added Cory Douglas, CFO of the Company. For full-year 2013, Medidata raised its guidance and now expects revenues to be in the range of $275.3 million to $276.8 million. The Full Research Report on Medidata Solutions, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/05dd_MDSO] MedAssets, Inc. Research Report On October 30, 2013, MedAssets, Inc. (MedAssets) reported its Q3 2013 financial results. In the quarter, the Company's net revenue increased 1.8% YoY to $166.4 million. Net income was $6.9 million, or $0.11 per diluted share in Q3 2013, compared with $5.5 million, or $0.09 per diluted share, in Q3 2012. For full-year 2013, the MedAssets expect net revenue to be between $671 million and $677 million, representing a growth of 4.8% to 5.8% YoY. Also, the Company expects full-year 2013 GAAP diluted EPS to be in the range of $0.39 to $0.43. The Full Research Report on MedAssets, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/0913_MDAS] EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to making mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. http://www.analystscorner.com/ SOURCE Analysts' Corner Contact: Joe Thomas; +1-310-496-8071
Strategic Acquisitions, Quarterly Financial Results and Updated Earnings Guidance - Research Report on CSC, Cerner, WebMD,
Press spacebar to pause and continue. Press esc to stop.